EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives

Marco Cascella, Raffaela Di Napoli, Domenico Carbone, Gaia Francesca Cuomo, Sabrina Bimonte, Maria Rosaria Muzio

Recenti Progressi in Medicina · 01.11.2018 · 109 (11)

DOI: 10.1701/3031.30289 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recenti Progressi in Medicina, erschienen am 01.11.2018. Verfasst von Marco Cascella und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anesthesia and Pain Management, Department of Supportive Care, Istituto Nazionale Tumori Fondazione G. Pascale - IRCSS, Naples, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The term chemotherapy-related cognitive impairment (CRCI), or cognitive dysfunction, or chemo fog, or chemo brain, is referred to a decline in a variety of neuropsychological tasks after chemotherapy, or following other anticancer treatments such as radiation therapy or surgery, in patients with non-central nervous system cancers. Furthermore, several pieces of evidence suggest that clinical manifestations of cognitive impairment may occur in cancer patients, prior to chemotherapy or in those not treated with cancer therapies. In these circumstances, it should be more appropriate to use the term cancer-related cognitive dysfunction. Because there is no consensus about its definition and diagnostic criteria, no specific test for CRCI diagnose exists. Whatever the cause, this manifestation of central nervous system toxicity is of increasing concern as the survival rates for cancer have improved steadily and, in turn, cognitive dysfunction can negatively impact the patients and cancer survivors’ quality of life. The aim of this work is to offer an overview of the topic and recommendations for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCancer SurvivorsCognitionCognitive DysfunctionHumansNeoplasmsQuality of Life

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of Anesthesia and Pain Management, Department of Supportive Care, Istituto Nazionale Tumori Fondazione G. Pascale - IRCSS, Naples, Italy.
  • Department of Anesthesiology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
  • Department of Emergency Medicine, Umberto I Hospital, Nocera Inferiore, Salerno, Italy.
  • Division of Infantile Neuropsychiatry, UOMI-Maternal and Infant Health, ASL NA3 SUD Torre del Greco, Naples, Italy.

Zitieren

APA

Cascella, M., Di Napoli, R., Carbone, D., Cuomo, G. F., Bimonte, S., & Muzio, M. R. (2018). Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives. Recenti Progressi in Medicina, 109(11). https://doi.org/10.1701/3031.30289

Vancouver

Cascella M, Di Napoli R, Carbone D, Cuomo GF, Bimonte S, Muzio MR. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives. Recenti Progressi in Medicina. 2018;109(11). doi:10.1701/3031.30289

BibTeX
@article{Cascella2018,
  author = {Cascella, Marco and Di Napoli, Raffaela and Carbone, Domenico and Cuomo, Gaia Francesca and Bimonte, Sabrina and Muzio, Maria Rosaria},
  title = {Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives},
  journal = {Recenti Progressi in Medicina},
  year = {2018},
  volume = {109},
  number = {11},
  doi = {10.1701/3031.30289}
}
Kostenlos starten →